| Title: | Affymetrix at Morgan Stanley 2008 Global Healthcare Unplugged Conference Transcript |
| Price: | $54.00 |
| Publication Date: | May 01, 2008 |
| Source: | Thomson StreetEvents |
| Report Type: | Transcript |
| Abstract: | Final Transcript of AFFX presentation, 1-May-08 11:20am ET |
| Brief Excerpt: | ... - Morgan Stanley - AnalystPerfect. Thank you. Let's go ahead and get started. In case you don't know me my name is David Lewis. I'm a member of the medical device team here. Medical technology team here at Morgan Stanley. It's a pleasure to have with us here heading into the luncheon session the management team here from Affymetrix. We have both the CFO, John Batty, as well as the VP of Investor Relations, Doug Farrell. So for those of you who do not know Affymetrix, I want to give a quick spiel, ## seconds or so, on Affymetrix and what we think is interesting about the Company. For most of you who know Affymetrix has been a pretty significant participant in the Life Sciences tools continuum here for many, many years, with obviously their principal GeneChip technology. For a very long period of time that technology was mostly used for the R&A side of the world, the [RM], MRNA expression side of the world and now we have seen with more recent products that Affy is starting to compete... |
| Word Count: | 8102 |
| Length: | 13 Pages |
| Ticker: | AFFX |
| Time: | 11:20am ET |
| Related Report(s): | |
| Format: | 
Adobe Acrobat
|
| Free Sample: |
Click
Here
to Download
|
Looking For Something Else?
